trending Market Intelligence /marketintelligence/en/news-insights/trending/cujwe9um2yrvifmyuuwwcq2 content esgSubNav
In This List

Gujarat Themis Biosyn appoints director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Gujarat Themis Biosyn appoints director

Gujarat Themis Biosyn Ltd. appointed Namjin Park as an additional director of the Indian drugmaker.

Park will be representing Yuhan Corp. on the board. He has been working with Yuhan Corp. since 1994 and was designated as executive director in April.

Hinesh Doshi will be an alternate director to Park. He is a senior partner at Hinesh R. Doshi and Co LLP.